ASX
Neuren Pharmaceuticals
NEU:ASX•Healthcare
Sensitive ASX Announcement
Record Q2 DAYBUE net sales of US$125m, CY26 royalty upgraded
Published: 05/08/26, 09:52am (AEST)•3 pages